コーパス検索結果 (1語後でソート)
  通し番号をクリックするとPubMedの該当ページを表示します
  
   1 pairs both CD8 T cell infiltration and acute skin graft rejection.                                   
     2 nting CBK but not third-party B10.A (H2k+Dd) skin graft rejection.                                   
     3 - T cells, however, had no influence on male skin graft rejection.                                   
     4 skin grafts; T-cell recovery correlated with skin graft rejection.                                   
     5 imulatory blockade and to inhibit allogeneic skin graft rejection.                                   
     6 D8+ T cells produce RANTES during allogeneic skin graft rejection.                                   
     7 scular injury that resembles human first-set skin graft rejection.                                   
     8 fficient class I antigen expression to cause skin graft rejection.                                   
     9 d to the CD8+ T effector cells requisite for skin graft rejection.                                   
    10 ry mediators and accelerate T cell-meditated skin graft rejection.                                   
    11 reviously recognized) features of allogeneic skin graft rejection: (1) that rejection can be initiate
  
  
    14 ed T cells in a SCID reconstitution model of skin graft rejection and are important in T cell accumul
    15 plore the involvement of Langerhans cells in skin graft rejection and describe fascinating results.  
  
    17 nd endothelium was examined using allogeneic skin graft rejection as a model of cutaneous inflammatio
  
    19 his cell line specifically induced a form of skin graft rejection characterized by the presence of TH
    20  no inhibition or even acceleration of donor skin graft rejection compared with non-DST control (naiv
    21 od subtly yet reproducibly decreases time to skin graft rejection elicited by central but not effecto
    22 G-Neutrophils, were confirmed by third-party skin graft rejection; importantly, a graft-versus-leukem
    23 n to donor cells is supported by accelerated skin graft rejection in mice transplanted with sca+ cell
  
  
  
    27  drug-modified DCs prior to transplantation, skin graft rejection kinetics were similar to those in n
    28 ored by mixed lymphocyte culture (MLC), CML, skin graft rejection, liver biopsies, and serial serum c
    29 ates that subsequent to T cell initiation of skin graft rejection, platelets contribute to further T 
  
    31  OVA, exhibited a somewhat delayed first set skin graft rejection response with lower allo-specific C
    32 dily mounted first and second set allogeneic skin graft rejection responses, and developed primary an
    33 ly unreactive in certain other assays, e.g., skin graft rejection; responses to MHC alloantigens, by 
    34 allopeptide can mediate a form of allogeneic skin graft rejection that exhibits characteristics of a 
  
    36 diac rejection, chronic renal rejection, and skin graft rejection were compared using CD20 or CD19 mA
    37 umab (anti-CD3 mAb) and found it could delay skin graft rejection, whereas ipilimumab (anti-CTLA-4 [c
    38 s was originally defined by the phenotype of skin graft rejection, which is a complex genetic trait. 
    39 pecific Treg cells significantly delayed CBK skin graft rejection without any other immunosuppression
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。